{"id":9943,"date":"2025-10-03T23:18:17","date_gmt":"2025-10-03T23:18:17","guid":{"rendered":"https:\/\/www.europesays.com\/lt\/9943\/"},"modified":"2025-10-03T23:18:17","modified_gmt":"2025-10-03T23:18:17","slug":"nustatytas-nepastebetas-ibuprofeno-poveikis-kepenu-sveikatai","status":"publish","type":"post","link":"https:\/\/www.europesays.com\/lt\/9943\/","title":{"rendered":"Nustatytas nepasteb\u0117tas ibuprofeno poveikis kepen\u0173 sveikatai"},"content":{"rendered":"<p>Ibuprofenas priklauso nesteroidini\u0173 vaist\u0173 nuo u\u017edegimo (NVNU) grupei ir da\u017eniausiai vartojamas skausmui mal\u0161inti, u\u017edegimui ma\u017einti ar kar\u0161\u010diavimui reguliuoti. Nors pla\u010diai \u017einoma, kad NVNU gali didinti \u0161irdies lig\u0173 ar insulto rizik\u0105, \u0161is tyrimas ypating\u0105 d\u0117mes\u012f skiria j\u0173 \u012ftakai kepen\u0173 sveikatai.<\/p>\n<p>Tyrimo, kurio rezultatai paskelbti mokslo \u017eurnale \u201eScientific Reports\u201c, metu mokslininkai pel\u0117ms kasdien vien\u0105 savait\u0119 dav\u0117 ibuprofeno doz\u0119, atitinkan\u010di\u0105 400 mg per dien\u0105 suaugusiam \u017emogui. Po eksperiment\u0173 kepen\u0173 l\u0105stel\u0117s buvo tiriamos pasitelkus moderni\u0105 mas\u0117s spektrometrijos technologij\u0105, leid\u017eian\u010di\u0105 detaliai \u012fvertinti biocheminius poky\u010dius.<\/p>\n","protected":false},"excerpt":{"rendered":"Ibuprofenas priklauso nesteroidini\u0173 vaist\u0173 nuo u\u017edegimo (NVNU) grupei ir da\u017eniausiai vartojamas skausmui mal\u0161inti, u\u017edegimui ma\u017einti ar kar\u0161\u010diavimui reguliuoti.&hellip;\n","protected":false},"author":2,"featured_media":9944,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[6],"tags":[25,30,31,34,35,24,3788,630,32,33,37,39,36,38,40,23,22,28,29,26,27,612],"class_list":{"0":"post-9943","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-antrastes","8":"tag-antrastes","9":"tag-breaking-news","10":"tag-breakingnews","11":"tag-featured-news","12":"tag-featurednews","13":"tag-headlines","14":"tag-ibuprofenas","15":"tag-kepenys","16":"tag-latest-news","17":"tag-latestnews","18":"tag-lietuva","19":"tag-lietuviu","20":"tag-lithuania","21":"tag-lithuanian","22":"tag-lt","23":"tag-naujienos","24":"tag-news","25":"tag-populiariausios-naujienos","26":"tag-populiariausiosnaujienos","27":"tag-top-stories","28":"tag-topstories","29":"tag-vaistai"},"share_on_mastodon":{"url":"","error":""},"_links":{"self":[{"href":"https:\/\/www.europesays.com\/lt\/wp-json\/wp\/v2\/posts\/9943","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.europesays.com\/lt\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.europesays.com\/lt\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/lt\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/lt\/wp-json\/wp\/v2\/comments?post=9943"}],"version-history":[{"count":0,"href":"https:\/\/www.europesays.com\/lt\/wp-json\/wp\/v2\/posts\/9943\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/lt\/wp-json\/wp\/v2\/media\/9944"}],"wp:attachment":[{"href":"https:\/\/www.europesays.com\/lt\/wp-json\/wp\/v2\/media?parent=9943"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.europesays.com\/lt\/wp-json\/wp\/v2\/categories?post=9943"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.europesays.com\/lt\/wp-json\/wp\/v2\/tags?post=9943"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}